Scioto Biosciences

About:

Scioto is a developer of Activated Bacterial Therapeutics platform.

Website: http://sciotobiosciences.com

Top Investors: National Institutes of Health, BioCrossroads, Genome & Co., Rev1 Ventures, Pathway Bioventures

Description:

Scioto Biosciences is a developer of Activated Bacterial Therapeutics (ABT) platform intended to deliver live bacteria to the gut. The company is developing innovative therapies devoted to having a transformative impact on the delivery of microbiome therapeutics, enabling medical practitioners to advance healing through microbiome therapeutics.

Total Funding Amount:

$31M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Indianapolis, Indiana, United States

Founded Date:

2017-01-01

Founders:

James Schulz, Joseph Trebley

Number of Employees:

11-50

Last Funding Date:

2020-08-10

IPO Status:

Private

Industries:

© 2025 bioDAO.ai